<code id='D5C24F0872'></code><style id='D5C24F0872'></style>
    • <acronym id='D5C24F0872'></acronym>
      <center id='D5C24F0872'><center id='D5C24F0872'><tfoot id='D5C24F0872'></tfoot></center><abbr id='D5C24F0872'><dir id='D5C24F0872'><tfoot id='D5C24F0872'></tfoot><noframes id='D5C24F0872'>

    • <optgroup id='D5C24F0872'><strike id='D5C24F0872'><sup id='D5C24F0872'></sup></strike><code id='D5C24F0872'></code></optgroup>
        1. <b id='D5C24F0872'><label id='D5C24F0872'><select id='D5C24F0872'><dt id='D5C24F0872'><span id='D5C24F0872'></span></dt></select></label></b><u id='D5C24F0872'></u>
          <i id='D5C24F0872'><strike id='D5C24F0872'><tt id='D5C24F0872'><pre id='D5C24F0872'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:5
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          FDA sets aggressive timeline for overhauling inspection procedures
          FDA sets aggressive timeline for overhauling inspection procedures

          AdobeWASHINGTON—FoodandDrugAdministrationofficialshopetofinishthisyearamassiveoverhaulofthewaytheage

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Head of FDA's diagnostics center, who led through Covid, retires

          TimothyStenzelledtheFDA'sdiagnosticsdivisionduringtheCovid-19pandemic,astheagencyscrambledtopushthro